Skip to main content
SpringerLink
Log in

Cabazitaxel + prednisone: compassionate-use safety findings

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Heidenreich A, Albers P, Bokemeyer C, Goebell P, Gschwend J, Miller K, Muller S, Otremba B, Reuter C, Trojan L, Volkmer B, Wirth M.Cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel-containing regimen: Interim analysis on treatment associated side effects resulting from a compassionate-use programme (CUP). 27th Congress of the European Association of Urology: abstr. 128, 24 Feb 2012. Available from: URL: http://www.uroweb.org/events/abstracts-online/?aid=38081

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cabazitaxel + prednisone: compassionate-use safety findings. React. Wkly. 1394, 3 (2012). https://doi.org/10.2165/00128415-201213940-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201213940-00005

Keywords

Search

Navigation